Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research
Felicia Ceban, Alexia Leber, Muhammad Youshay Jawad, et al.
Infectious Diseases (2022) Vol. 54, Iss. 7, pp. 467-477
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study
Tala Ballouz, Dominik Menges, A Anagnostopoulos, et al.
BMJ (2023), pp. e074425-e074425
Open Access | Times Cited: 124
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
Felicia Ceban, Dana Kulzhabayeva, Nelson B. Rodrigues, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 211-229
Open Access | Times Cited: 63
S1-Leitlinie Long-/Post-COVID
Andreas Rembert Koczulla, Tobias Ankermann, Uta Behrends, et al.
Pneumologie (2022) Vol. 76, Iss. 12, pp. 855-907
Open Access | Times Cited: 64
Clinical trials on the pharmacological treatment of long COVID: A systematic review
Ying Jie Chee, Bingwen Eugene Fan, Barnaby Edward Young, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 60
Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems
Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3113-3113
Open Access | Times Cited: 53
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial
Roger S. McIntyre, Lee Phan, Angela T.H. Kwan, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 849-857
Closed Access | Times Cited: 28
Long COVID in low-income and middle-income countries: the hidden public health crisis
Waasila Jassat, Luis Felipe Reyes, Daniel Munblit, et al.
The Lancet (2023) Vol. 402, Iss. 10408, pp. 1115-1117
Open Access | Times Cited: 25
The definition of long COVID used in interventional studies
Alyson Haslam, Timothée Olivier, Vinay Prasad
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 8
Closed Access | Times Cited: 21
Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors
Marco Colizzi, Maddalena Peghin, Maria De Martino, et al.
Revista de Psiquiatría y Salud Mental (2022) Vol. 16, pp. 38-46
Open Access | Times Cited: 34
Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation
Fabrizio Salvucci, Roberto Codella, Adriana Coppola, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study
Philipp A. Reuken, Bianca Besteher, Kathrin Finke, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023)
Open Access | Times Cited: 16
Global respiratory health priorities at the beginning of the 21st century
Catherine M. Greene, Mohamed Abdulkadir
European Respiratory Review (2024) Vol. 33, Iss. 172, pp. 230205-230205
Open Access | Times Cited: 6
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 5
Current landscape of long COVID clinical trials
Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111930-111930
Closed Access | Times Cited: 5
Bayesian Modeling of the Impact of HBOT on the Reduction in Cytokine Storms
Natalia Jermakow, Klaudia Brodaczewska, Jacek Kot, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1180-1180
Open Access
A Machine-Learning Approach to Finding Gene Target Treatment Options for Long COVID
Alejandro Lopez‐Rincon
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Exploring requirements for the development and implementation of VR rehabilitation programs for long/post COVID patients: a qualitative mixed-methods study
Katharina Dalko, Hlynur Andri Elsuson, Sebastian Hofstetter, et al.
Virtual Reality (2025) Vol. 29, Iss. 2
Open Access
Post-COVID: effects of physical exercise on functional status and work ability in health care personnel
Timothy Hasenoehrl, Stefano Palma, Dominikus Huber, et al.
Disability and Rehabilitation (2022) Vol. 45, Iss. 18, pp. 2872-2878
Open Access | Times Cited: 24
Epipharyngeal Abrasive Therapy (EAT) Has Potential as a Novel Method for Long COVID Treatment
Kazuaki Imai, Takafumi Yamano, Soichiro Nishi, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 907-907
Open Access | Times Cited: 22
Comparability of Control and Comparison Groups in Studies Assessing Long COVID
Alyson Haslam, Vinay Prasad
The American Journal of Medicine (2023)
Open Access | Times Cited: 12
A lifestyle adjustments program in long COVID-19 improves symptomatic severity and quality of life. A randomized control trial
Alba Navas‐Otero, Andrés Calvache‐Mateo, Irene Calles-Plata, et al.
Patient Education and Counseling (2024) Vol. 122, pp. 108180-108180
Open Access | Times Cited: 4
Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan
Yoshihiro Noda, Akiko Sato, Misaki Shichi, et al.
Asian Journal of Psychiatry (2022) Vol. 81, pp. 103438-103438
Open Access | Times Cited: 19
Alleviation of Post-COVID-19 Cognitive Deficits by Treatment with EGb 761®: A Case Series
Udo Zifko, Muhammad Yacob, Benedikt J. Braun, et al.
American Journal of Case Reports (2022) Vol. 23
Open Access | Times Cited: 14
Motivational Interviewing as a Tool to Increase Motivation and Adherence to a Long COVID Telerehabilitation Intervention: Secondary Data Analysis from a Randomized Clinical Trial
Sandra León-Herrera, Bárbara Oliván‐Blazquez, Mario Samper-Pardo, et al.
Psychology Research and Behavior Management (2024) Vol. Volume 17, pp. 157-169
Open Access | Times Cited: 2
Sleep and Long COVID—A Review and Exploration of Sleep Disturbances in Post Acute Sequelae of SARS-COV-2 (PASC) and Therapeutic Possibilities
Elliott K. Lee, R. Robert Auger
Current Sleep Medicine Reports (2024) Vol. 10, Iss. 2, pp. 169-180
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top